Keyphrases
Endometrioid
100%
Uterine Cancer
100%
Para-aortic Lymphadenectomy
100%
Pelvic Lymphadenectomy
42%
No Significant Difference
28%
Overall Survival
28%
Multivariate Analysis
14%
Pathological Findings
14%
Prospective Randomized Trial
14%
Therapeutic Benefits
14%
Medical Records
14%
Confidence Interval
14%
High Risk
14%
Odds Ratio
14%
High-risk Population
14%
Therapeutic Efficacy
14%
Clinical High Risk
14%
FIGO Stage I
14%
Histopathological Factors
14%
Comprehensive Surgical Staging
14%
Deep Myometrial Invasion
14%
Medicine and Dentistry
Retroperitoneal Lymph Node Dissection
100%
Uterine Cancer
100%
Pelvis
57%
Pelvis Lymphadenectomy
42%
Overall Survival
28%
Recurrent Disease
14%
Multivariate Analysis
14%
Medical Record
14%
Population Research
14%
High Risk Population
14%
Combination Therapy
14%
Odds Ratio
14%